An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Klaus Schmiegel (born June 28, 1939), is most famous for his work in organic chemistry, which led to the invention of Prozac, a widely used antidepressant. Born in Chemitz, Germany, he moved to the U.S. in 1951 to continue his education. After he finished his schooling, Schmiegel joined Eli Lilly as a senior organic chemist; he worked there from 1968 until his retirement in 1993. There, he collaborated with Bryan Molloy to create a new group of compounds. One of them, fluoxetine hydrochloride, became the selective serotonin reuptake inhibitor (SSRI) used in the antidepressant medication, Prozac. The drug, approved by the U.S. Food and Drug Administration (FDA) in 1988, has revolutionized treatment for depression. In 1999, Schmiegel and Molloy were inducted into the National Inventors Hall

Property Value
dbo:abstract
  • Klaus Schmiegel (* 28. Juni 1939 in Chemnitz) ist ein deutschamerikanischer Erfinder und Chemiker. (de)
  • Klaus Schmiegel (born June 28, 1939), is most famous for his work in organic chemistry, which led to the invention of Prozac, a widely used antidepressant. Born in Chemitz, Germany, he moved to the U.S. in 1951 to continue his education. After he finished his schooling, Schmiegel joined Eli Lilly as a senior organic chemist; he worked there from 1968 until his retirement in 1993. There, he collaborated with Bryan Molloy to create a new group of compounds. One of them, fluoxetine hydrochloride, became the selective serotonin reuptake inhibitor (SSRI) used in the antidepressant medication, Prozac. The drug, approved by the U.S. Food and Drug Administration (FDA) in 1988, has revolutionized treatment for depression. In 1999, Schmiegel and Molloy were inducted into the National Inventors Hall of Fame and given the American Innovator Award. Throughout his career, Schmiegel garnered eighteen patents related to the synthesis of compounds. (en)
  • Klaus Kurt Schmiegel (Chemnitz, 28 de junho de 1939) é um químico orgânico alemão radicado nos Estados Unidos. É conhecido pela invenção do Prozac, um antidepressivo largamente utilizado. Mudou-se para os Estados Unidos em 1951, a fim de continuar seus estudos. (pt)
dbo:academicDiscipline
dbo:almaMater
dbo:award
dbo:birthDate
  • 1939-06-28 (xsd:date)
dbo:knownFor
dbo:residence
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 20279706 (xsd:integer)
dbo:wikiPageLength
  • 8361 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1095547610 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
  • University of MichiganDartmouth CollegeStanford University (en)
dbp:awards
  • National Inventors Hall of Fame, 1999American Innovator Award, 1999 (en)
dbp:birthDate
  • 1939-06-28 (xsd:date)
dbp:birthPlace
  • Chemnitz, Germany (en)
dbp:fields
dbp:knownFor
  • Inventing fluoxetine, the active ingredient in Prozac (en)
dbp:name
  • Klaus Schmiegel (en)
dbp:nationality
  • German (en)
dbp:residence
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Klaus Schmiegel (* 28. Juni 1939 in Chemnitz) ist ein deutschamerikanischer Erfinder und Chemiker. (de)
  • Klaus Kurt Schmiegel (Chemnitz, 28 de junho de 1939) é um químico orgânico alemão radicado nos Estados Unidos. É conhecido pela invenção do Prozac, um antidepressivo largamente utilizado. Mudou-se para os Estados Unidos em 1951, a fim de continuar seus estudos. (pt)
  • Klaus Schmiegel (born June 28, 1939), is most famous for his work in organic chemistry, which led to the invention of Prozac, a widely used antidepressant. Born in Chemitz, Germany, he moved to the U.S. in 1951 to continue his education. After he finished his schooling, Schmiegel joined Eli Lilly as a senior organic chemist; he worked there from 1968 until his retirement in 1993. There, he collaborated with Bryan Molloy to create a new group of compounds. One of them, fluoxetine hydrochloride, became the selective serotonin reuptake inhibitor (SSRI) used in the antidepressant medication, Prozac. The drug, approved by the U.S. Food and Drug Administration (FDA) in 1988, has revolutionized treatment for depression. In 1999, Schmiegel and Molloy were inducted into the National Inventors Hall (en)
rdfs:label
  • Klaus Schmiegel (de)
  • Klaus Schmiegel (en)
  • Klaus Schmiegel (pt)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • Klaus Schmiegel (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License